Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-Q, Date: 2011-05-10
Original SEC Filing: Click here

---

Webplus: CPHI/20110510/10-Q_1/1/000.htm SEC Original: cphi10q033111.htm
FORM 10-Q (Mark One) x March 31, 2011 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer’s telephone number, including area code)

---

---

Webplus: CPHI/20110510/10-Q_1/2_EX-31.1/000.htm SEC Original: cphi10qex311033111.htm
CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were

---

---

Webplus: CPHI/20110510/10-Q_1/3_EX-31.2/000.htm SEC Original: cphi10qex312033111.htm
CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were

---

---

Webplus: CPHI/20110510/10-Q_1/4_EX-32.1/000.htm SEC Original: cphi10qex321033111.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 10, 2011 ——————————– President and Chief Executive Officer EX-32.1 4 cphi10qex321033111.htm

---

---

Webplus: CPHI/20110510/10-Q_1/5_EX-32.2/000.htm SEC Original: cphi10qex322033111.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 10, 2011 ——————— (principal financial officer and principal accounting officer) EX-32.2 5 cphi10qex322033111.htm

---

Company Information:

Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-Q, Date: 2011-05-10CIK: 0001106644, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
2ND FLOOR, NO. 17, JINPAN ROAD, HAIKOU
HAINAN PROVINCE 570216